Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-56.64	11.49	26.49
Graham Fair Price	41.42	30.10	21.28
PEG	-76.83	0.07	-0.31
Price/Book	22.62	3.28	2.68
Price/Cash Flow	34.40	12.76	9.50
Prices/Earnings	-38.69	7.22	11.78
Price/Sales	-38.57	1.43	2.32
Price/FCF	34.40	12.76	9.50
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-10.63	0.10	0.11
Operating Margin	16.11	0.09	0.08
ROA	89.05	0.03	0.02
ROE	0.06	0.11	100.00
ROIC	0.04	0.09	118.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.20	-0.22	-7.08
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.39	1.32	236.88
EPS QOQ	-0.38	1.00	164.62
FCF QOQ	2.80	-0.09	-96.87
Revenue QOQ	-0.48	1.00	107.43
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	102.90	50.90	-50.53
Days Sales Outstanding (DSO)	80.46	46.49	-42.22
Inventory Turnover	0.87	1.77	102.16
Debt/Capitalization	0.31	0.35	13.00
Quick Ratio	0.47	0.81	74.68
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	18.82	18.82	0.00
Cash	0.00	14.88	100.00
Capex	2.08	-1.62	-21.87
Free Cash Flow	5.31	4.84	-8.76
Revenue	21.70	43.31	99.62
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.09	1.32	20.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.81	-0.95	-75.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating